Clinical trial · Observational
Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer
Feasibility of an Evidence-based Walking Program in a Sample of Men Age >65 Undergoing Treatment for Prostate Cancer
NCT02139774CI-TRIAL-00020077terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): inadequate accrual
Summary
Brief summary (as posted)
This study is testing a walking program called Walk with Ease by the Arthritis Foundation with men undergoing treatment for prostate cancer. The researchers are interested in how easy or difficult it is for these men to participate in this program and whether or not is is helpful to them during their care.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Walk with Ease | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- label
- Active Survelliance
- description
- Men age 65 and older who are undergoing active surveillance as primary treatment for their prostate cancer.
- interventionNames
- Behavioral: Walk with Ease
- label
- Radiation
- description
- Men age 65 and older who are undergoing radiation only as primary treatment for their prostate cancer.
- interventionNames
- Behavioral: Walk with Ease
- label
- Endocrine Therapy
- description
- Men age 65 and older who are undergoing endocrine therapy as primary treatment for their prostate cancer.
- interventionNames
- Behavioral: Walk with Ease
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * ≥65 years of age * Histologically confirmed Stage I, II or III prostate cancer (endocrine (± radiation) patients may be Stage IV) * Undergoing prostate cancer treatment (post-surgery only, radiation only, endocrine therapy (± radiation), or active surveillance) * English speaking * IRB approved, signed written informed consent * Approval from their treating physician to engage in moderate-intensity physical activity * Patient-assessed ability to walk and engage in moderate physical activity * Willing and able to meet all study requirements Exclusion Criteria: * One or more significant medical conditions that in the physician's judgment preclude participation in the walking intervention * Major surgery scheduled within the study period * Unable to walk or engage in moderate-intensity physical activity * Already actively walking (150 minutes per week)
References
Publications (0)
Data not yet available
No reference posted for this study.